Efficacy of Sucralfate in the Postoperative Management of Uvulopalatopharyngoplasty: A Double-blind, Randomized, Controlled Study | Otolaryngology | JAMA Otolaryngology–Head & Neck Surgery | JAMA Network
[Skip to Navigation]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address Please contact the publisher to request reinstatement.
Fujita  SConway  WZorick  FRoth  T Surgical correction of anatomic abnormalities in obstructive sleep apnea syndrome: uvulopalatopharyngoplasty.  Otolaryngol Head Neck Surg 1981;89923- 934PubMedGoogle Scholar
Kamami  YV Laser CO2 for snoring: preliminary results.  Acta Otorhinolaryngol Belg 1990;44451- 456PubMedGoogle Scholar
Freeman  SBMarkwell  JK Sucralfate in alleviating post-tonsillectomy pain.  Laryngoscope 1992;1021242- 1246PubMedGoogle ScholarCrossref
Leach  JManning  SSchaefer  S Comparison of two methods of tonsillectomy.  Laryngoscope 1993;103619- 622PubMedGoogle ScholarCrossref
Raj  TBWickham  MH The effect of benzydamine hydrochloride (Difflam) spray on post-tonsillectomy symptoms: a double-blind study.  J Laryngol Otol 1986;100303- 306PubMedGoogle ScholarCrossref
Anderson  HARice  BJCantrell  RW Effects of injected deposteroid on posttonsillectomy morbidity: a double-blind study.  Arch Otolaryngol 1975;10186- 88PubMedGoogle ScholarCrossref
Nagashima  R Mechanism of action of sucralfate.  J Clin Gastroenterol 1981;3117- 127PubMedGoogle Scholar
Bednarczyk  EM Sucralfate.  In:  Physicians Drug Handbook. Springhouse, Pa: Springhouse Corp; 1993:988Google Scholar
Rattan  JSchneider  MArber  NGorsky  MDayan  D Sucralfate suspension as a treatment of recurrent aphthous stomatitis.  J Intern Med 1994;236341- 343PubMedGoogle ScholarCrossref
Tsakayannis  DLi  WWRazvi  SSpirito  N Sucralfate and chronic venous stasis ulcers.  Lancet 1994;343424- 425PubMedGoogle ScholarCrossref
Nottage  MMcLachlan  SABrittain  MA  et al.  Sucralfate mouthwash for prevention of 5-fluorouracil–induced mucositis: a randomized, placebo-controlled trial.  Support Care Cancer 2003;1141- 47PubMedGoogle Scholar
Kyrmizakis  DEPapadakis  CEBizakis  JGVelegrakis  GASiafakas  NMHelidonis  ES Sucralfate alleviating post–laser-assisted uvulopalatoplasty pain.  Am J Otolaryngol 2001;2255- 58PubMedGoogle ScholarCrossref
Original Article
October 2006

Efficacy of Sucralfate in the Postoperative Management of Uvulopalatopharyngoplasty: A Double-blind, Randomized, Controlled Study

Author Affiliations

Author Affiliations: Department of Otorhinolaryngology–Head and Neck Surgery, Communication Disorder Institute of Medical Science Research Center, Korea University College of Medicine, Seoul, South Korea.

Arch Otolaryngol Head Neck Surg. 2006;132(10):1082-1085. doi:10.1001/archotol.132.10.1082

Objective  To evaluate the effectiveness of sucralfate in influencing throat pain, otalgia, analgesic requirement, bleeding, mucosal recovery, and incidence of postoperative bleeding in patients undergoing uvulopalatopharyngoplasty.

Design  A prospective double-blind randomized study.

Setting  University-affiliated tertiary referral hospital.

Participants  Eighty adult patients with obstructive sleep apnea syndrome requiring uvulopalatopharyngoplasty were recruited and randomly allocated into either a sucralfate treatment group or a control group.

Interventions  All patients underwent uvulopalatopharyngoplasty. Patients enrolled in the sucralfate group (n = 40) were instructed to gargle the sucralfate suspension and then to swallow. Patients enrolled in the control group (n = 40) were instructed to gargle placebo suspension at the same doses and schedule.

Main Outcome Measures  Postoperative throat pain, otalgia, amount of analgesic required, degree of strength (defined as patients' general well-being and return to regular daily activities), percentage of mucosal covering, and postoperative bleeding.

Results  Throat pain and otalgia occurred significantly less often in sucralfate group, with less analgesic requirement and with rapid mucosal healing and early return to regular daily activities. There was no significant difference in episodes of postoperative bleeding between the 2 groups (P = .37).

Conclusions  Although sucralfate therapy may not provide complete analgesia after uvulopalatopharyngoplasty, it may reduce the amount of analgesic required, thus preventing dose-related adverse effects from the analgesic agent. It can also significantly reduce the total number of days needed to return to normal daily activities (P = .41).